Diagnostic Methods
AssigneesUniversite De Geneve, Electrophoretics Limited
InventorsLoic Gerard Dayon, Jean-Charles Sanchez, Joan Montaner Villalonga
Life of this patent
Estimating the term…
Loading patent…
AssigneesUniversite De Geneve, Electrophoretics Limited
InventorsLoic Gerard Dayon, Jean-Charles Sanchez, Joan Montaner Villalonga
Estimating the term…
The invention relates to a method of aiding the diagnosis of acute brain damage in a subject, said method comprising (i) assaying the concentration of at least one oxidative stress polypeptide selected from the group consisting of: PRDX1, PRDX6 and GSTP1 in a sample from said subject; and (ii) assaying the concentration of at least one further polypeptide selected from Panel A; (Hi) comparing the concentrations of (i) and (ii) to the concentrations of the polypeptides in a reference standard and determining quantitative ratios for said polypeptides; (iv) wherein a finding of a quantitative ratio of each of the assayed polypeptides in the sample to the polypeptides in the reference standard of greater than 1.3 indicates an increased likelihood of acute brain damage having occurred in said subject.
1-42. (canceled)
A method of aiding the diagnosis of acute brain damage in a subject, the method comprising:
An assay device, which comprises a solid substrate having a location containing a material, which recognizes, binds to or has affinity for a first and a second polypeptide or a fragment, variant, or mutant thereof, wherein the first polypeptide is selected from PRDX1, PRDX6 and GSTP1 and the second polypeptide is selected from Panel A.
An assay device, which comprises a solid substrate having a location containing a material, which recognizes, binds to or has affinity for a polypeptide, or a fragment, variant, or mutant thereof, wherein the polypeptide is selected from Panel 2.
A method of diagnosis or prognostic monitoring of acute brain damage in a subject, said method comprising:
A preparation comprising one or more synthetic peptides selected from the group listed in Table 14.
Dependencies are inferred from the claim text.